Discover a powerful, new (and somewhat unpopular) way to deal with anxiety and depression - without meditation, yoga, gratitude lists, pharmaceuticals and $49 Moleskine journals.
Similar Posts
Psychedelic Business Spotlight: June 11, 2021
This week in psychedelic business news: An all-female biotech company, psychedelic-assisted psychotherapy for COVID front-liners, and more.
Prolonged DMT Infusions could be a Breakthrough for Stroke Patients
Stroke recovery requires stimulating neuroplasticity to heal brain trauma, and prolonged DMT infusions may help speed this process
Interview with James Lanthier, CEO of Mindset Pharma
In our conversation, James goes into detail about Mindset’s new lead drug candidate MSP-1014, when the company expects to take the drug to clinical trials, and why next generation drugs are an important commercial opportunity for anyone looking to invest in the psychedelic sector.
Spotlight Roundup-Another Psychedelic Company Lists On The Nasdaq
June 9, 2021- This week’s Psychedelic Business News top stories…
U.K. Psychedelic R&D Company Investigates MDMA, Ketamine for Addiction
Awakn Life Sciences is looking at psychedelics for addiction, namely MDMA and ketamine for alcohol use disorder.
Octopuses On MDMA Want to Snuggle Just Like You
In the Netflix documentary My Octopus Teacher, filmmaker Craig Foster…